Diabetes news and diabetes widget

Living Cell Technologies Limited (ASX: LCT; OTCQX: LVCLY) today updated shareholders at their Annual General Meeting in Adelaide, Australia on the Phase I/IIa clinical trial of DiabeCell®, LCT's lead product candidate for the treatment of insulin dependent (Type 1) diabetes. A total of six patients have been implanted with DiabeCell® to date; five patients received the lowest dose of 5,000 islet equivalents (IEQ/kg), and one patient was dosed with 10,000 IEQ/kg.

The U.S. Food and Drug Administration is notifying health care professionals and patients that Tyco Healthcare Group LP (Covidien) is recalling one lot of ReliOn sterile, single-use, disposable, hypodermic syringes with permanently affixed hypodermic needles due to possible mislabeling. The use of these syringes may lead to patients receiving an overdose of as much as 2.5 times the intended dose, which may lead to hypoglycemia, serious health consequences, and even death.

Children born to mothers with pregnancy-related diabetes run twice the risk of language development problems, according to a research team directed by Professor Ginette Dionne of Université Laval's School of Psychology. Details of this discovery are published in the most recent issue of the scientific journal Pediatrics.

The recognition of health as a central economic and societal driving force requires new approaches to how health policy is conducted. Policy innovations - in particular mechanisms that recognize the critical role of patients and consumers and that involve a wide range of stakeholders - will be the defining factor for health sustainability in the 21st century.

Joslin diabetes Center today announced that C. Ronald Kahn, M.D., Head of the Joslin Section on Obesity and Hormone Action and the Mary K. Iacocca Professor of medicine at Harvard Medical School, has been named the first winner of the Manpei Suzuki International Prize for Diabetes Research. "Joslin Diabetes Center is delighted that one of our world-renowned researchers has been named the inaugural winner of such a prestigious award," said Ranch C.

HealthDay - SUNDAY, Nov. 9 (HealthDay News) -- Two large studies released Sunday cast doubt on the cardiac benefits of either low-dose aspirin or vitamin supplements.